Evidence-Based ‘OMICS in Clinical Practice
How do laboratory tools and advances in technology contribute to our understanding of health and disease, including the COVID-19 pandemic?
Join us for this year’s virtual conference on May 27 and 28 as we explore the evidence for ‘omics and utility in the health care setting – including COVID-19 and the lungs, depression and gut inflammation, novel platforms in cancer treatment, nutrition, and more.
Associate Professor, Department of Psychiatry and Behavioural Neurosciences, McMaster University
Professor, Pathology and Molecular Medicine, McMaster University
Associate Professor, Biochemistry and Biomedical Sciences, McMaster University
Professor of Medicine, McMaster University
Professor, Department of Biochemistry, University of Toronto
Russell de Souza
Associate Professor, Department of Health Research Methods, Evidence, and Impact, McMaster University
Research Director, Laboratory of Nutrition and Integrative Neurobiology (INRAE), University of Bordeaux
Clinical Assistant Professor, University of British Columbia
The ‘OMICS and Epidemiology conference is hosted by the Population Genomics Program at McMaster – Canada’s most research-intensive university.
The Population Genomics Program (PGP) mobilizes McMaster’s expertise and resources in population health, genomics, clinical trials and health-research methodology to investigate the influences of gene-gene and gene-environment interactions on disease. It fosters interdisciplinary collaborations among clinical researchers and basic scientists to marshal new insights and discoveries in the burgeoning field of population genomics at McMaster.
The PGP applies the disciplines of epidemiology, biostatistics and computational biology to reveal and interpret the complex relationships between single nucleotide polymorphisms (SNPS) and other DNA sequence patterns in individuals and the expression of common complex diseases including respiratory disease, autism, obesity, infectious and immunological diseases, type 2 diabetes and cardiovascular diseases in populations.